Carrier Is Organic Patents (Class 436/528)
-
Patent number: 6662113Abstract: A method for determining the physical, chemical, or biological correlation between test samples in group A and test samples in group B. This correlation can be determined by contacting a mixture of test samples selected according to a certain rule from group A with test samples from group B to detect the interaction(s) between them. The number of reactions needed to detect these interaction(s) is greatly reduced by preparing a mixture of test samples in group A according to the principle of binary notation, and thus enables a rapid screening.Type: GrantFiled: November 23, 1999Date of Patent: December 9, 2003Assignee: Fujisawa Pharmaceutical Co., Ltd.Inventors: Nobuyoshi Shimizu, Shuichi Asakawa
-
Patent number: 6660532Abstract: The invention provides a reagentless assay kit for analyte in a sample comprising a modular affinity assembly including at least one sensor unit comprising a ligand having binding affinity for the analyte (affinity module) operatively associated with a reporter probe (reporter module) responsive to changes in the sensor unit induced by analyte/receptor complex formation by transduction of a characteristic detectable signal. Assays employing the modular assembly are also provided.Type: GrantFiled: December 16, 1999Date of Patent: December 9, 2003Assignee: Science & Technology Corporation @ UNMInventors: Gabriel P. Lopez, Larry A. Sklar, Philip Hampton, Leonard Tender, Kimberly Opperman, Emmanuel Rabinovich, Ravinder K. Jain, Juchao Yan
-
Patent number: 6660484Abstract: The present invention relates to methods and compositions for the direct detection of analytes using observable spectral changes in biopolymeric systems. In particular, the present invention allows for the direct colorimetric detection of analytes using color changes that occur in glycopolythiophene polymer systems in response to selective binding of analytes.Type: GrantFiled: December 11, 2000Date of Patent: December 9, 2003Assignee: Regents of the University of CaliforniaInventors: Deborah J. Charych, Myung-Gi Baek
-
Patent number: 6649354Abstract: The present invention involves a method for assaying a substance. The method of the present invention comprises contacting the substance with an assay agent comprising a catalytic agent to associate the substance with the catalytic agent, contacting the resulting associated substance with a label precursor capable of reacting catalytically with the catalytic agent to release the label, and detecting a mass label. The present invention also involves a kit for assaying a substance. The kit of the present invention comprises an assay agent comprising a catalytic agent, and a label precursor capable of reacting catalytically with the catalytic agent to release a mass label.Type: GrantFiled: May 3, 2000Date of Patent: November 18, 2003Assignee: Xzillion GmbH & Co.Inventors: Gunter Schmidt, Andrew Hugin Thompson
-
Patent number: 6635420Abstract: The invention concerns a method for the purification of a target substance from a biological sample by immobilizing the target substance on a solid phase by means of a high affinity binding pair and subsequently eluting it by adding a partner of the binding pair in a free form. In addition reagent kits for carrying out the method are disclosed.Type: GrantFiled: October 13, 2000Date of Patent: October 21, 2003Assignee: Roche Diagnostics GmbHInventors: Wolfgang Hosel, Helmut Lenz, Jochen Peter
-
Patent number: 6630358Abstract: Protein arrays for the parallel, in vitro screening of biomolecular activity are provided. Methods of using the protein arrays are also disclosed. On the arrays, a plurality of different proteins, such as different members of a single protein family, are immobilized on one or more organic thinfilms on the substrate surface. The protein arrays are particularly useful in drug development, proteomics, and clinical diagnostics.Type: GrantFiled: May 12, 2000Date of Patent: October 7, 2003Assignee: Zyomyx, IncorporatedInventors: Peter Wagner, Dana Ault-Riche, Steffen Nock, Christian Itin
-
Patent number: 6617116Abstract: Assay devices, kits, and methods for detection of one or more analytes in a sample are provided. The assay device features the controlled release of reagents and hence is particularly suitable for binding assays such as immunoassays. The assay device achieves greater sensitivity than conventional rapid test assays, leading to stronger and/or more stable visual signals than those produced by conventional devices, easier interpretation of results, and reduced occurrence of indeterminate results. The device can be used for detecting analyte in a variety of biological samples without the need for conventional sample filtration techniques, and thus is suitable for use by untrained personnel without specialized equipment. In addition, the device can be used to simultaneously analyze a number of analytes using a single sample.Type: GrantFiled: January 25, 2001Date of Patent: September 9, 2003Assignee: Genelabs Diagnostics Pte. Ltd.Inventors: Ming Guan, Hsiao Ying Chen
-
Publication number: 20030166033Abstract: Methods of determining collagen degradation in vivo, by quantitating the concentration of a peptide in a body fluid, the peptide being a C-terminal type II collagen telopeptide containing a hydroxylysyl pyridinoline cross-link or a type III collagen telopeptide containing a hydroxylysyl pyridinoline cross-link. Suitable methods include immunometric assays, fluorometric assays, and electrochemical titrations for quantitation. The structures of specific peptides having cross-links and kits for quantitating these peptides in a body fluid are described.Type: ApplicationFiled: March 7, 2003Publication date: September 4, 2003Applicant: Washington Research FoundationInventor: David R. Eyre
-
Patent number: 6613582Abstract: The present application describes novel uses of ruthenium bipyridyls or palladium porphyrins as photo-activatable crosslinking agents. Crosslinking can be between any two molecules including peptides, proteins, or compounds. Crosslinking occurs in the presence of an electron donor such as ammonium persulfate, and requires only moderate intensity visible light. Crosslinking can be between peptides, polypeptides or lead candidate compounds to unknown target molecules. Reagents utilyzing ruthenium bipyridyls and palladium porphyrins crosslinkers for use in diagnostic and detection scenarios are also disclosed.Type: GrantFiled: May 25, 2000Date of Patent: September 2, 2003Assignee: Board of Regents, The University of Texas SystemInventors: Thomas J. Kodadek, David A. Fancy, Stephen A. Johnston
-
Patent number: 6607891Abstract: A pretreatment method for assaying a substance which comprises mixing a biological specimen with at least one pretreating agent selected from among surfactants and alkali agents, thus releasing binding proteins in the biological specimen from the substance to be assayed and, at the same time, inactivating the proteins by irreversible denaturation to thereby eliminate the effects of the binding proteins coexisting in the biological specimen.Type: GrantFiled: January 31, 2001Date of Patent: August 19, 2003Assignee: Mitsubishi Chemical CorporationInventor: Makoto Takada
-
Patent number: 6602661Abstract: The present invention is directed to a device and a method for detecting biomolecules in a tissue section or other two-dimensional sample by creating “carbon copies” of the biomolecules eluted from the sample and visualizing the biomolecules on the copies using antibodies or DNA probes having specific affinity for the biomolecules of interest. Thin membranes in a stacked or layered configuration are applied to the sample, such as a tissue section, and reagents and reaction conditions are provided so that the biomolecules are eluted from the sample and transferred onto each of the stacked membranes thereby producing multiple replicas of the biomolecular content of the sample.Type: GrantFiled: November 20, 2000Date of Patent: August 5, 2003Assignees: 20/20 GeneSystems, Inc., The United States of America as represented by the Department of Health and Human ServicesInventors: Vladimir Knezevic, Michael R. Emmert-Buck
-
Patent number: 6602716Abstract: A method and device for fluorimetric determination of a biological, chemical or physical parameter of a sample utilize at least two different luminescent materials, the first of which is sensitive to the parameter, at least with respect to luminescence intensity, and the second of which is insensitive to the parameter, at least with respect to luminescence intensity and decay time. The luminescent materials have different decay times. The time- or phase behaviour of the resulting luminescence response is used to form a reference value for determination of a parameter.Type: GrantFiled: April 10, 2000Date of Patent: August 5, 2003Assignee: PreSens Precision Sensing GmbHInventor: Ingo Klimant
-
Patent number: 6602692Abstract: In a method for immobilizing biomolecules and affinity ligands water insoluble matrices, having amino groups and selected from test tubes, microtiter plates, microscope slides, beads, membranes, resins, and filters, are reacted with a cyclobutene carboxylic acid derivative, such as cyclobutene carboxylic acid diester, cyclobutene carboxylic acid halide, cyclobutene carboxylic acid ester halide, cyclobutene carboxylic acid dialkoxyester, and cyclobutene carboxylic acid imidazole, as an activating compound in methanol and triethylamine to form active matrices with active groups. A protein containing at least one primary or secondary amino group, is dissolved and added to the matrices. The activated matrices and the dissolved protein are incubated at pH of 7-10 and a temperature of +4° C. to +60° C. in an aqueous buffer system, free of primary and secondary amines, to thereby immobilize the protein on the matrices.Type: GrantFiled: June 6, 1996Date of Patent: August 5, 2003Inventors: Karl-Heinz Glüsenkamp, Gertrud Eberle-Adamkiewics
-
Patent number: 6602719Abstract: A disposable, dry chemistry analytical system is disclosed which is broadly useful for the detection of a variety of analytes present in biological fluids such as whole blood, serum, plasma, urine and cerebral spinal fluid. The invention discloses the use of the reaction interface that forms between two liquids converging from opposite directions within a bibulous material. The discovery comprises a significant improvement over prior art disposable, analytical reagent systems in that the detectable reactant zone is distinct and separate from the unreacted reagents allowing for the use of reaction indicators exhibiting only minor changes as well as extremely high concentrations of reactants. In addition, staged, multiple reagents can be incorporated. Whole blood can be used as a sample without the need for separate cell separating materials.Type: GrantFiled: March 26, 1999Date of Patent: August 5, 2003Assignee: IDEXX Laboratories, Inc.Inventor: Charles Carpenter
-
Patent number: 6596502Abstract: The invention concerns a home kit and a method for detection of the presence of a fecal parasite in a stool.Type: GrantFiled: March 15, 2001Date of Patent: July 22, 2003Assignee: Lee Research Laboratory, Inc.Inventor: Martin Jerome Lee
-
Patent number: 6593085Abstract: A method of assaying for an analyte including the steps of: (i) passing a sample suspected of containing an analyte and reagents comprising a target ligand-analyte receptor conjugate and a detectable tracer containing a label for the analyte through filter apparatus containing a plurality of discrete flow zones wherein at least one zone functions as a capture zone having bonded thereto a receptor ligand for said target ligand; (ii) allowing the sample and accompanying reagents to incubate prior to passage through said at least one zone to facilitate formation of complex(es) of said conjugate and said at least one analyte in a liquid or fluid phase; and (iii) detecting the presence of analyte in the sample by activation of the label in said at least one zone after binding of the complex(es) conjugate to the associated receptor ligand(s).Type: GrantFiled: November 13, 2000Date of Patent: July 15, 2003Assignee: Panbio Pty LtdInventors: Graeme Ross Barnett, Roy L. Manns
-
Patent number: 6589731Abstract: A sensor element is provided including a polymer exhibiting a measurable property from the group of luminescence and electrical conductivity, the polymer being complexed with a unit including a recognition element, a tethering element and a property-altering element bound thereto so as to alter the measurable property, the unit being susceptible of subsequent separation from the polymer upon exposure to an agent having an affinity for binding to the recognition element whereupon the separation of the unit from the polymer results in a detectable change in the measurable property.Type: GrantFiled: May 4, 2000Date of Patent: July 8, 2003Assignee: The Regents of the University of CaliforniaInventors: Liaohai Chen, Duncan W. McBranch, Hsing-Lin Wang, David G. Whitten
-
Patent number: 6582912Abstract: A device for dosing at least a particular constituent in a product sample has a receptacle and a cover assembled to form a closed container having a vertical axis. The receptacle and cover bear coaxial cylindrical walls defining concentric annular chambers inside the container, the walls separating chambers each having an opening, the cover and the container being rotatable relative to each other about the vertical axis, said openings being placed in a predetermined manner so that by relative displacement of the walls, the openings are positioned in a straight line or offset to communicate, or isolate said successive chambers. A method for using such a device and an apparatus for implementing said method are disclosed.Type: GrantFiled: August 14, 2000Date of Patent: June 24, 2003Assignee: Stago InternationalInventors: Alain Rousseau, Michel Canton
-
Patent number: 6582969Abstract: Methods for the parallel, in vitro screening of biomolecular activity using miniaturized microfabricated devices are provided. The biomolecules that can be immobilized on the surface of the devices of the present invention include proteins, polypeptides, nucleic acids, polysaccharides, phospholipids, and related unnatural plyomers of biological relevance. These devices are useful in high-throughput drug screening and clinical diagnostics and are preferably used for the parallel screening of families of related proteins.Type: GrantFiled: May 12, 2000Date of Patent: June 24, 2003Assignee: Zyomyx, Inc.Inventors: Peter Wagner, Dana Ault-Riche, Steffen Nock, Christian Itin
-
Patent number: 6579687Abstract: Methods and compositions are described for the detection and quantitation of cardiac specific troponin I and troponin T in samples. Cardiac-specific troponin isoforms exist in various forms in the blood, including free and complexed forms. By selecting antibodies that are sensitive and/or insensitive to these various forms, the present invention can provide immunoassays that more accurately reflect the clinical state of an individual. These described methods and compositions can be used for providing indicators of myocardial infarction and other cardiac pathologies.Type: GrantFiled: October 21, 1999Date of Patent: June 17, 2003Assignee: Biosite IncorporatedInventors: Kenneth F. Buechler, Paul H. McPherson
-
Patent number: 6576460Abstract: The present invention relates to a filtration-detection device for detecting or quantifying an analyte in a test sample including a filtration device having a first binding material immobilized thereto, wherein the first binding material is capable of binding to a portion of the analyte, and a detection assembly positioned relative to the filtration device to detect or quantify analyte bound to the first binding material. The present invention also relates to methods of using the filtration-detection device.Type: GrantFiled: October 27, 2000Date of Patent: June 10, 2003Assignees: Cornell Research Foundation, Inc., Innovative Biotechnologies International, Inc.Inventors: Antje J. Baeumner, Richard A. Montagna
-
Patent number: 6576461Abstract: An electrochemical affinity assay system for detection of ligand—ligand receptor binding.Type: GrantFiled: June 18, 2001Date of Patent: June 10, 2003Assignee: Therasense, Inc.Inventors: Adam Heller, Charles N. Campbell
-
Patent number: 6576429Abstract: An apparatus for taking an intestinal sample of a human or animal patient comprises a holder part (1) and an expandable part (2) supported by the holder part and having one or more sampling areas (8) on the surface thereof. The expandable part (2) is in a non-expanded state rectally insertable into and retractable from the patient's intestine, and in an expanded state, inserted into the patient's intestine, the expandable part is capable of contacting the intestinal wall with at least one sampling area (8; 14). The apparatus further comprises protective livers (7a, 7b) for preventing said sampling area or areas (8) from contact with the intestinal wall and intestinal fluid at least when the expandable part (2) in the non-expanded state is being rectally inserted into the patient's intestine.Type: GrantFiled: October 26, 2000Date of Patent: June 10, 2003Assignee: Alimenta Diagnostics ABInventor: Roger Hällgren
-
Patent number: 6576425Abstract: Methods for testing oligonucleotide arrays are disclosed including methods for testing the efficiency of nucleotide coupling; methods for testing amounts of deprotected oligonucleotides; methods for determining amounts of depurinated oligonucleotides; and methods of detecting the presence of cleavable structural features, such as double-stranded nucleic acids.Type: GrantFiled: February 8, 2001Date of Patent: June 10, 2003Assignee: Affymetrix, Inc.Inventors: Glenn McGall, Anthony D. Barone, Martin Diggelmann, David J. Lockhart, Ann Maria Caviani Pease, Mark Chee
-
Patent number: 6573109Abstract: The present invention relates to a membrane for use in detecting the presence of an analyte. The membrane comprises an array of closely packed self-assembling amphiphilic molecules and a plurality of first and second receptor molecules, the first receptor molecules being reactive with one site on the analyte and second receptor molecules being reactive with another site on the analyte. The first receptor molecules are prevented from lateral diffusion within the membrane whilst the second receptor molecules are free to diffuse laterally within the membrane. The membrane is characterized in that the ratio of first receptor molecules to second receptor molecules is 10:1 or greater.Type: GrantFiled: October 10, 1995Date of Patent: June 3, 2003Assignees: Australian Membrane and Biotechnology Research Institute, The University of SydneyInventors: Bruce A. Cornell, Ronald J. Pace
-
Publication number: 20030100130Abstract: A semiconductor nanocrystal compound is described capable of linking to an affinity molecule. The compound comprises (1) a semiconductor nanocrystal capable of emitting electromagnetic radiation and/or absorbing energy, and/or scattering or diffracting electromagnetic radiation—when excited by an electromagnetic radiation source or a particle beam; and (2) at least one linking agent, having a first portion linked to the semiconductor nanocrystal and a second portion capable of linking to an affinity molecule. The compound is linked to an affinity molecule to form a semiconductor nanocrystal probe capable of bonding with a detectable substance. subsequent exposure to excitation energy will excite the semiconductor nanocrystal in the probe causing the emission of electromagnetic radiation.Type: ApplicationFiled: May 24, 2002Publication date: May 29, 2003Inventors: Shimon Weiss, Marcel Bruchez, Paul Alivisatos
-
Publication number: 20030092201Abstract: A method of treating particles to be used in immunoassays reduces interference in particle agglutination assays.Type: ApplicationFiled: November 2, 2001Publication date: May 15, 2003Inventors: Christopher C. Lawrence, Wei Yuan, Armen B. Shanafelt
-
Analytical assay device and methods using surfactant treated membranes to increase assay sensitivity
Patent number: 6558959Abstract: An analytical device comprising a surfactant-treated porous reaction membrane having an exposed sample-contacting surface and at least one receptor area located in a limited region of the exposed sample-contacting surface. The limited region has a higher concentration of surfactant than areas of the sample-contacting surface that are peripheral to the limited region. To make the device, a surfactant-containing solution comprising at least 0.2% surfactant is added to the reaction membrane and allowed to dry. Then, a receptor reagent is added to a limited region of the reaction membrane. In the assay, the surfactant causes the liquid sample to flow faster through the portion(s) of the reaction membrane where receptor molecules are located.Type: GrantFiled: July 11, 2001Date of Patent: May 6, 2003Inventor: Albert E. Chu -
Patent number: 6555391Abstract: This invention relates methods for conditioning affinity chromatography resins to decrease leaching of the ligand during purification. The methods involve incubating the resin in a buffered solution of a hydroxyalkylamine compound (e.g., ethanolamine) prior to use of the resin for an affinity purification. The treatment removes unstably bound ligand from the resin.Type: GrantFiled: August 15, 2000Date of Patent: April 29, 2003Assignee: Baxter International, Inc.Inventors: Susan L. Bernhard, Robert Toso, Van Taiariol
-
Patent number: 6555656Abstract: A prion-physiological structure and associated method of formation. A provided abnormal prion has a transforming power over a normal prion to convert the abnornal prion into defective prion that mimics the abnormal prion. A linker molecule is then bonded to the abnormal prion, wherein a polymer that is covalently attached to the linker molecule facilitates formation of a polymerized abnormal prion that does not have the transforming power over the normal prion.Type: GrantFiled: May 18, 2001Date of Patent: April 29, 2003Assignee: Albany Medical CollegeInventor: Mark D. Scott
-
Patent number: 6555390Abstract: A chromatographic assay or test device for detection and/or determination of an analyte in a test sample, comprises a base member, and a chromatographic medium located in or on said base member, the base member being provided with a receptacle to receive an applicator having the sample applied thereto, and the applicator being movable when located in said receptacle between a first position in which the applicator is out of fluid contact with the chromatographic medium, and a second position in which the applicator is in fluid contact with the chromatographic medium so as to apply a sample on the applicator to the chromatographic medium. In an alternative aspect, the test device comprises a base member, and a second member, at least one of the base member and the second member including a chromatographic medium, and the second member being slidably movable with respect to the base member from a first position to a second position.Type: GrantFiled: May 10, 1999Date of Patent: April 29, 2003Inventor: Howard Milne Chandler
-
Patent number: 6551842Abstract: A disposable, dry chemistry analytical system is disclosed which is broadly useful for the detection of a variety of analytes present in biological fluids such as whole blood, serum, plasma, urine and cerebral spinal fluid. The invention discloses the use of the reaction interface that forms between two liquids converging from opposite directions within a bibulous material. The discovery comprises a significant improvement over prior art disposable, analytical reagent systems in that the detectable reactant zone is visually distinct and separate from the unreacted reagents allowing for the use of reaction indicators exhibiting only minor changes as well as extremely high concentrations of reactants. In addition, staged, multiple reagents can be incorporated. Whole blood can be used as a sample without the need for separate cell separating materials.Type: GrantFiled: March 14, 2000Date of Patent: April 22, 2003Assignee: IDEXX Laboratories, Inc.Inventor: Charles R. Carpenter
-
Patent number: 6548310Abstract: A particle for a diagnostic agent, which comprises a polymer particle comprising (A) from 20 to 100% by weight of a structural unit derived from at least one of acrylate having an aliphatic hydrocarbon group and methacrylate having an aliphatic hydrocarbon group, (B) from 0 to 10% by weight of a structural unit derived from unsaturated carboxylic acid, and (C) from 0 to 80% by weight of a structural unit derived from a vinyl monomer copolymerizable with the acrylate, methacrylate and unsaturated carboxylic acid, and a turbidmetric immunoassay using the same.Type: GrantFiled: February 1, 2000Date of Patent: April 15, 2003Assignee: JSR CorporationInventors: Mitsuhiro Murata, Satoshi Katayose, Kiyoshi Kasai, Mikio Hikata, Toru Masukawa, Masaaki Kitajima
-
Patent number: 6548309Abstract: In qualitative or quantitative assays which employ a test device comprising a test strip pretreated for detection of a specified target analyte dissolved in a liquid medium, the presence of solid, semisolid and/or colloidal materials in the liquid medium may interfere with the assay results. The present invention involves collecting the sample from a flowing or quiescent pool of liquid also containing solid, semisolid or colloidal material with a swab comprised of a handle and a mass of fibrous material or foamed, open cell material which, when immersed in and thoroughly wetted by the liquid, entraps solid, semisolid and/or colloidal material and delivers only the liquid to the sample receiving zone of the test strip.Type: GrantFiled: March 19, 1998Date of Patent: April 15, 2003Assignee: Binax, Inc.Inventors: Norman James Moore, Vincent Anthony Sy
-
Patent number: 6541270Abstract: A colorimetric detector for chemical and biological agents or toxins is made of a giant unilamellar vesicle (GUV) having a membrane bilayer which is polymerized to stabilize the giant unilamellar vesicle and to provide extended conjugated polymer backbone, and the GUV has at least one incorporated molecular recognition site for the chemical and biological agents or toxins. The GUVs are about 10-300 microns and preferably made of a polymerizable diacetylenic GUV where the acyl chains are crosslinked. When the agents or toxins bind to the recognition site the detector exhibits a color change. The detector can be used in a colorimetric detector apparatus where the samples can be present in air or in water.Type: GrantFiled: January 16, 2001Date of Patent: April 1, 2003Assignee: The United States of America as represented by the Secretary of the NavyInventors: Alok Singh, Paul Schoen
-
Patent number: 6537829Abstract: The invention provides methods, compositions, and apparatus for performing sensitive detection of analytes, such as biological macromolecules and other analytes, by labeling a probe molecule with an up-converting label. The up-converting label absorbs radiation from an illumination source and emits radiation at one or more higher frequencies, providing enhanced signal-to-noise ratio and the essential elimination of background sample autofluorescence. The methods, compositions, and apparatus are suitable for the sensitive detection of multiple analytes and for various clinical and environmental sampling techniques.Type: GrantFiled: December 1, 1999Date of Patent: March 25, 2003Assignee: SRI InternationalInventors: David A. Zarling, Michel J. Rossi, Norman A. Peppers, James Kane, Gregory W. Faris, Mark J. Dyer, Steve Y. Ng, Luke V. Schneider
-
Patent number: 6537744Abstract: Sensitive methods using a variety of biomarkers in oral saliva of humans and animals to detect, measure, and quantify the presence of infectious and non-infectious agents and the functional status of living tissues in both (1) biomedical and (2) environmental applications. With the in vivo biomedical applications, saliva samples are taken from human or animal subjects and biomarkers, such as enzyme or antibody levels, are measured. The extent of exposure to an agent is measured by the presence of specific chemical or biological constituents, by the degree of the inhibition of enzymes, or by the changes in the amount of the biochemicals in saliva. With the in vitro environmental applications, enzymes or other biochemicals from animal or human saliva can be used to monitor the presence of toxic or reactive agents in tissue samples, urine, feces, milk, air, water, soil, or plants. The amount of toxicant in samples is estimated from a standard curve for that agent.Type: GrantFiled: November 10, 1997Date of Patent: March 25, 2003Inventor: Mohammed A. S. Al-Bayati
-
Patent number: 6534270Abstract: Disclosed are biochips having a high detecting sensitivity with readiness in fabrication of microarray, and a method for fabricating the same, in which a solid support wound with fibers is immersed in a solution containing biomolecules to immobilize the biomolecules onto the fiber, and the individual fibers with the biomolecules immobilized thereon are straightened and arranged. The arranged fibers are embedded with a defined material and cut in a direction perpendicular to the lengthwise arrangement direction of the fibers to obtain thin chips. The chips are placed on a substrate to remove the material used for embedding and thereby remain fibers with the immobilized biomolecules on the substrate. This biochip fabrication method immobilizes a great number of biomolecules onto the fibers having a large surface area to enhance the detection sensitivity and allows production of a great number of substrates with an array of biomolecules immobilized simultaneously.Type: GrantFiled: April 12, 2001Date of Patent: March 18, 2003Assignee: LG Electronics Inc.Inventors: Su Hyeon Kim, Je Kyun Park, Tae Han Kim
-
Patent number: 6534321Abstract: A method for analyzing a sample containing a plurality of analytes, comprises labelling the analytes with a detectable label, the label being chosen such that its detectability can be influenced by modifying the conditions of detection; separating the labelled analytes, before or after labeling,; and determining the presence of the separated analytes under the modified conditions and also, if desired, the unmodified conditions. Suitable detection apparatus comprises a support for a gel, means for detecting one or more analytes in the gel, and means for reducing the temperature of the gel to below ambient temperature, e.g., to no more than 0°C.Type: GrantFiled: January 8, 1999Date of Patent: March 18, 2003Assignee: Oxford GlycoSciences (UK) Ltd.Inventors: Rajesh Bhikhu Parekh, Paul Nicholas Goulding, Dale Robert Pfost
-
Patent number: 6531278Abstract: Compositions and methods of use thereof for capture and detection of selected molecules are described. In one embodiment, a first composition includes a ligand component, such as an antibody coupled to a nucleic acid component. An a preferred embodiment, the nucleic acid is labeled with a fluorescent marker to facilitate detection. Another aspect of the invention is the ligand component bound to a solid support via a complementary nucleic acid component and a linker moiety. The method involves binding the target with the first composition in free solution, then binding the target to the solid support by means of both DNA hybridization and antibody-antigen affinity binding. Unbound molecules are washed away, and then the bound targets are detected by fluorescence detection. Vital stains can also be used to detect viable cells.Type: GrantFiled: January 14, 1999Date of Patent: March 11, 2003Assignee: Utah State UniversityInventor: Bart Weimer
-
Patent number: 6528323Abstract: A test strip adapted to receive a sample and detect an analyte therein is provided. The test strip comprises a sample addition zone to which a sample may be added; an absorbent zone proximal to the sample addition zone; one or more test zones distal to the sample addition zone, at least one of the test zones including a first analyte binding agent immobilized therein which is capable of binding to the analyte to be detected; and a terminal sample flow zone distal to the one or more test zones, the absorbent zone being positioned relative to the sample addition zone and having an absorption capacity relative to the other zones of the test strip such that a distal diffusion front of a sample added to the sample addition zone diffuses from the sample addition zone to a distal diffusion point within the terminal sample flow zone and then reverses direction and diffuses proximal relative to the one or more test zones.Type: GrantFiled: June 14, 1999Date of Patent: March 4, 2003Assignee: Praxsys Biosystems, Inc.Inventors: Richard M. Thayer, Alan J. Polito, Robert K. Dinello, George H. Sierra, Henry J. Wieck
-
Patent number: 6528321Abstract: A chromatographic assay device according to the present invention provides a unidirectional immunoassay for an analyte in a whole blood sample with improved sensitivity and freedom from interference.Type: GrantFiled: June 26, 2000Date of Patent: March 4, 2003Assignee: Beckman Coulter, Inc.Inventors: Daniel Fitzgerald, Howard M. Chandler, Larry LaPointe
-
Patent number: 6528322Abstract: The invention relates to a method for qualitative, semi-quantitative or quantitative determination of at least two analytes in an aqueous sample containing or suspected of containing the analytes, which method comprises the steps of: (i) providing a flow matrix comprising a separation zone extending in a first dimension thereof, and a detection zone extending in the first dimension in a spaced parallel relationship with the separation zone, the detection zone comprising an immobilized reagent capable of capturing the analytes through biospecific interaction therewith, (ii) applying the sample to the flow matrix at or upstream of the separation zone, (iii) initiating a first essentially aqueous fluid flow in the flow matrix along the separation zone in the first dimension to transport the analytes through the separation zone to be separated therein, (iv) interrupting the first fluid flow and initiating a second essentially aqueous fluid flow in a second dimension of the flow matrix substantially transverseType: GrantFiled: August 4, 2000Date of Patent: March 4, 2003Assignee: Pharmacia ABInventors: Jan Carlsson, Maria Lönnberg
-
Patent number: 6514771Abstract: A method and apparatus for the manipulation of colloidal particulates and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution. Light-controlled electrokinetic assembly of particles near surfaces relies on the combination of three functional elements: the AC electric field-induced assembly of planar aggregates; the patterning of the electrolyte/silicon oxide/silicon interface to exert spatial control over the assembly process; and the real-time control of the assembly process via external illumination. The present invention provides a set of fundamental operations enabling interactive control over the creation and placement of planar arrays of several types of particles and biomolecules and the manipulation of array shape and size. The present invention enables sample preparation and handling for diagnostic assays and biochemical analysis in an array format, and the functional integration of these operations.Type: GrantFiled: October 17, 2000Date of Patent: February 4, 2003Assignee: Bioarray SolutionsInventor: Michael Seul
-
Patent number: 6514773Abstract: Subject matter of the invention is a method for detecting surface contamination by an analyte by wiping the analyte off the surface with the aid of a wiping surface, eluting the analyte from the wiping surface with an eluant, and detecting the analyte in the eluate in an immunological detection reaction, characterized in that: a) the surface to be tested for the analyte is wiped with a wiping surface, b) the wiping surface is brought into contact with the planar surface of a capillary active, chromatographic test strip which has an eluant application zone at its one end and a target zone at its other end whereby contact is made in an area between these two zones, c) eluting liquid is applied onto the zone provided for this purpose, said liquid moving toward the target zone passes the contact site with the wiping surface as a consequence of capillary forces, whereby analyte is taken up by the eluant, and d) in the target zone, the analyte is measured in an immunological binding reaction.Type: GrantFiled: July 24, 1995Date of Patent: February 4, 2003Assignee: Securetec Detektions-Systeme AGInventors: Christian Klein, Hans-Peter Josel, Ada Goerlach-Graw, Reinhold Hilpert, Florian Binder, Josef Ritter, Rudolf Zimmermann
-
Patent number: 6511812Abstract: An improved method for detecting antibodies is disclosed. The method employs a recombinant denatured bacterial enzyme. The invention also relates to a test kit useful for performing an immunoassay which comprises a container containing a denatured recombinant bacterial enzyme.Type: GrantFiled: November 12, 1996Date of Patent: January 28, 2003Assignee: Abbott LaboratoriesInventors: Robert C. Schoen, Yuzo Inoue, Toshinori Takei, Satoshi Jomura, Susan E. Sweeney, Joseph S. Niedbalski
-
Patent number: 6511814Abstract: A disposable, dry chemistry analytical system is disclosed which is broadly useful for the detection of a variety of analytes present in biological fluids such as whole blood, serum, plasma, urine and cerebral spinal fluid. The invention discloses the use of the reaction interface that forms between two liquids converging from opposite directions within a bibulous material. The discovery comprises a significant improvement over prior art disposable, analytical reagent systems in that the detectable reactant zone is visually distinct and separate from the unreacted reagents allowing for the use of reaction indicators exhibiting only minor changes as well as extremely high concentrations of reactants. In addition, staged, multiple reagents can be incorporated. Whole blood can be used as a sample without the need for separate cell separating materials.Type: GrantFiled: November 12, 1999Date of Patent: January 28, 2003Assignee: Idexx Laboratories, Inc.Inventor: Charles R. Carpenter
-
Patent number: 6511798Abstract: Cell based screens for studying drug transport are described and improved methods for the preparation of cell monolayers for use in such screens are disclosed.Type: GrantFiled: March 16, 1999Date of Patent: January 28, 2003Assignee: Zeneca LimitedInventor: Charles Michael Shaw
-
Patent number: 6509148Abstract: Disclosed is a method for fabricating biosensors, using hydrophilic polyurethane. Bio-active reagents, including enzymes, antibodies, antigens, cells and receptors, are mixed with hydrophilic polyurethane and the mixture is directly coated over a signal transducer to form a sensing film which serves as a signal detector. The method using hydrophilic polyurethane allows the simplification of the fabrication of biosensors without conducting complicated chemical reactions and washing steps, such as crosslinking. The bio-active reagent entrapped within the hydrophilic polyurethane film can retains its high activity for an extended period of time and the intrinsic potentiometric response of the underlying ion-selective polymeric membrane is not affected by the bio-active reagent immobilized polyurethane film coated on its sensing surface. Therefore, the biosensors are superior in specificity, selectivity, and stability.Type: GrantFiled: February 10, 2000Date of Patent: January 21, 2003Assignee: i-Sens, Inc.Inventors: Geun Sig Cha, Hakhyun Nam, Jae Ho Shin
-
Patent number: 6506342Abstract: A combinatorial chemistry bead that includes an electromagnetic spectral emitter that radiates a distinct electromagnetic code for each bead that uniquely identifies each bead, a terminal apparatus for receiving the electromagnetic code from each bead, and a method for performing combinatorial synthesis using a bead that transmits a distinct electromagnetic code. The invention includes a large number of spectrally narrowed light emitting mechanisms for generating distinct optical codes.Type: GrantFiled: May 15, 2000Date of Patent: January 14, 2003Inventor: Robert D. Frankel